Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | $3,253.7M | $3,100.3M | $3,680.2M | $4,747.3M | $5,451.5M | $6,271.9M | $6,675.4M | $6,884.9M | $7,080.7M | $7,747.1M | $7,518.0M | $8,022.9M | $8,450.9M | $9,666.9M | $9,072.7M | $9,349.7M | $10.8B | $13.1B | $15.5B | $20.7B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Novo Nordisk A/S's last 12-month Current Assets is $29.1B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Novo Nordisk A/S's Current Assets growth was 44.8%. The average annual Current Assets growth rates for Novo Nordisk A/S have been 44.4% over the past three years, 25.8% over the past five years.
Over the last year, Novo Nordisk A/S's Current Assets growth was 44.8%, which is higher than industry growth of (0.1%). It indicates that Novo Nordisk A/S's Current Assets growth is Good.